Refractory Angioimmunoblastic T-cell Lymphoma

Also known as: Angioimmunoblastic T-cell lymphoma refractory

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB02379Beta-D-Glucose1Completed1
DB00958Carboplatin1Completed1
DB00531Cyclophosphamide1Completed1
DB00531Cyclophosphamide1Recruiting1
DB00773Etoposide1Completed1
DB14999Human interferon beta1Recruiting1
DB01181Ifosfamide1Completed1
DB06176Romidepsin1Completed1
DB08877Ruxolitinib1Recruiting1
DB11119Sodium iodide1Recruiting1
DB09037Pembrolizumab1 / 2Recruiting2
DB06813Pralatrexate1 / 2Recruiting1
DB06176Romidepsin1 / 2Recruiting1
DB08870Brentuximab vedotin2Not Yet Recruiting1
DB06132Nivolumab2Terminated1
DB09035Nivolumab2Terminated1
DB09037Pembrolizumab2Not Yet Recruiting1
DB14922Tislelizumab2Active Not Recruiting1
DB00928Azacitidine3Active Not Recruiting1
DB06769Bendamustine3Active Not Recruiting1
DB00441Gemcitabine3Active Not Recruiting1
DB06176Romidepsin3Active Not Recruiting1